No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 10, Pages -
Publisher
American Society for Microbiology
Online
2018-07-23
DOI
10.1128/aac.01064-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy
- (2017) Elham Shirvani-Dastgerdi et al. JOURNAL OF HEPATOLOGY
- Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study
- (2017) Scott Fung et al. JOURNAL OF HEPATOLOGY
- Brief Report
- (2016) David Wohl et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment
- (2016) Y. Liu et al. JOURNAL OF VIRAL HEPATITIS
- Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy
- (2015) Eisuke Murakami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate
- (2015) Christian Callebaut et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- No Resistance to Tenofovir Disoproxil Fumarate Through 96 Weeks of Treatment in Patients With Lamivudine-Resistant Chronic Hepatitis B
- (2014) Amoreena C. Corsa et al. Clinical Gastroenterology and Hepatology
- Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
- (2013) Scott Fung et al. GASTROENTEROLOGY
- Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load
- (2013) Stuart C. Gordon et al. HEPATOLOGY
- No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B
- (2013) Kathryn M. Kitrinos et al. HEPATOLOGY
- Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
- (2013) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance
- (2013) Fabien Zoulim et al. LIVER INTERNATIONAL
- De novo assembly of highly diverse viral populations
- (2012) Xiao Yang et al. BMC GENOMICS
- Mechanism for Effective Lymphoid Cell and Tissue Loading Following Oral Administration of Nucleotide Prodrug GS-7340
- (2012) Darius Babusis et al. MOLECULAR PHARMACEUTICS
- HBVdb: a knowledge database for Hepatitis B Virus
- (2012) J. Hayer et al. NUCLEIC ACIDS RESEARCH
- Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
- (2011) Chanunta Hongthanakorn et al. HEPATOLOGY
- HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A–H and its use in antiviral phenotyping assays
- (2011) Yuao Zhu et al. JOURNAL OF VIROLOGICAL METHODS
- Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
- (2010) S. J. Patterson et al. GUT
- Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
- (2009) Fabien Zoulim et al. GASTROENTEROLOGY
- Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
- (2009) Florian van Bömmel et al. HEPATOLOGY
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
- (2009) Daniel J. Tenney et al. HEPATOLOGY
- 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
- (2008) Yun–Fan Liaw et al. GASTROENTEROLOGY
- Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
- (2008) Stéphanie Villet et al. JOURNAL OF HEPATOLOGY
- Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance
- (2008) Bulent Degertekin et al. JOURNAL OF HEPATOLOGY
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now